These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21521801)

  • 1. Open innovation for phenotypic drug discovery: The PD2 assay panel.
    Lee JA; Chu S; Willard FS; Cox KL; Sells Galvin RJ; Peery RB; Oliver SE; Oler J; Meredith TD; Heidler SA; Gough WH; Husain S; Palkowitz AD; Moxham CM
    J Biomol Screen; 2011 Jul; 16(6):588-602. PubMed ID: 21521801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulin is a molecular target of the Wnt-activating chemical probe.
    Fukuda Y; Sano O; Kazetani K; Yamamoto K; Iwata H; Matsui J
    BMC Biochem; 2016 May; 17(1):9. PubMed ID: 27207629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays.
    Lee JA; Shinn P; Jaken S; Oliver S; Willard FS; Heidler S; Peery RB; Oler J; Chu S; Southall N; Dexheimer TS; Smallwood J; Huang R; Guha R; Jadhav A; Cox K; Austin CP; Simeonov A; Sittampalam GS; Husain S; Franklin N; Wild DJ; Yang JJ; Sutherland JJ; Thomas CJ
    PLoS One; 2015; 10(7):e0130796. PubMed ID: 26177200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
    Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
    Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic screening strategies for neurodegenerative diseases: a pathway to discover novel drug candidates and potential disease targets or mechanisms.
    Pruss RM
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):693-700. PubMed ID: 20942792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety screening in early drug discovery: An optimized assay panel.
    Bendels S; Bissantz C; Fasching B; Gerebtzoff G; Guba W; Kansy M; Migeon J; Mohr S; Peters JU; Tillier F; Wyler R; Lerner C; Kramer C; Richter H; Roberts S
    J Pharmacol Toxicol Methods; 2019; 99():106609. PubMed ID: 31284073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin secretory action of novel polycyclic guanidines: discovery through open innovation phenotypic screening, and exploration of structure-activity relationships.
    Shaghafi MB; Barrett DG; Willard FS; Overman LE
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1031-6. PubMed ID: 24484900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell network profiling (SCNP): mapping drug and target interactions.
    Covey TM; Putta S; Cesano A
    Assay Drug Dev Technol; 2010 Jun; 8(3):321-43. PubMed ID: 20158439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Identification of Pharmacological Targets from Small-Molecule Phenotypic Screens.
    Liu X; Baarsma HA; Thiam CH; Montrone C; Brauner B; Fobo G; Heier JS; Duscha S; Königshoff M; Angeli V; Ruepp A; Campillos M
    Cell Chem Biol; 2016 Oct; 23(10):1302-1313. PubMed ID: 27667560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
    Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
    J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Thermogenic Beige Cells to Identify Biologically Active Small Molecules and Peptides.
    Wu L; Xu B
    Methods Mol Biol; 2017; 1566():203-212. PubMed ID: 28244053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation.
    Liu Y; Platchek M; Kement B; Bee WT; Truong M; Zeng X; Hung S; Lin H; Morrow D; Kallal LA; Xie Q; Agarwal P; Pope AJ; Wu Z
    Mol Biosyst; 2014 Feb; 10(2):251-7. PubMed ID: 24257700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs).
    Callis R; Rabow A; Tonge M; Bradbury R; Challinor M; Roberts K; Jones K; Walker G
    J Biomol Screen; 2015 Jul; 20(6):748-59. PubMed ID: 25851036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Prioritization of Tool Compounds for Phenotypic Screening.
    Wang Y; Jenkins JL
    Methods Mol Biol; 2018; 1787():195-206. PubMed ID: 29736720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches.
    Lee JA; Berg EL
    J Biomol Screen; 2013 Dec; 18(10):1143-55. PubMed ID: 24080259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple statistical test to infer the causality of target/phenotype correlation from small molecule phenotypic screens.
    Wei X; Hoffman AF; Hamilton SM; Xiang Q; He Y; So WV; So SS; Mark D
    Bioinformatics; 2012 Feb; 28(3):301-5. PubMed ID: 22155864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion.
    Gallardo VE; Varshney GK; Lee M; Bupp S; Xu L; Shinn P; Crawford NP; Inglese J; Burgess SM
    Dis Model Mech; 2015 Jun; 8(6):565-76. PubMed ID: 25810455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.
    Okombo J; Chibale K
    Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building predictive models for mechanism-of-action classification from phenotypic assay data sets.
    Berg EL; Yang J; Polokoff MA
    J Biomol Screen; 2013 Dec; 18(10):1260-9. PubMed ID: 24088371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.